Intra-Arterial Celiac Axis Infusion Chemotherapy for Pancreatic Cancer at Medias Clinic Burghausen

Located in the historic town of Burghausen, Germany, the Medias Clinic stands as a specialized beacon of hope for patients facing advanced pancreatic cancer. Under the medical direction of Professor Karl R. Aigner, a pioneer with over four decades of experience in regional chemotherapy, the clinic offers a highly targeted treatment known as intra-arterial celiac axis infusion. Unlike traditional systemic chemotherapy, which circulates through the entire body and often causes debilitating side effects, this procedure delivers high-dose medication directly into the celiac trunk, the primary artery supplying the pancreas and surrounding organs. By threading a fine catheter through the femoral artery in the groin to the tumor’s doorstep, the medical team can achieve drug concentrations that are up to 20 times higher at the site of the cancer while sparing healthy tissues from the usual toxic impact. The Medias Clinic’s philosophy focuses on balancing intensive tumor destruction with a high quality of life. During treatment, patients receive a potent combination of agents, including cisplatin, mitomycin, and adriamycin. Studies conducted at the clinic on hundreds of patients with advanced stage III and IV pancreatic cancer have shown that this concentrated approach can lead to significant tumor shrinkage, even in cases previously deemed unresectable. For instance, landmark research involving 454 patients demonstrated that regional infusion not only improved median survival compared with standard systemic options but also provided immediate and lasting pain relief for the majority of participants. In some remarkable instances, the treatment reduced the tumor mass so effectively that it enabled "conversion surgery," allowing surgeons to remove what was once an inoperable growth. Choosing the Medias Clinic means entering an environment where therapy is tailored to the individual's specific vascular anatomy and tumor profile. Because the drugs are largely filtered out by the tumor and liver before reaching the rest of the body, patients often avoid the severe nausea, hair loss, and immune suppression associated with conventional methods. This gentle approach is particularly vital for pancreatic cancer, which is notoriously resistant to standard treatments.